成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

返回ChemicalBook首頁>CAS數據庫列表>293753-05-6

293753-05-6

中文名稱 SR3335
英文名稱 SR3335
CAS 293753-05-6
分子式 C13H9F6NO3S2
分子量 405.336
MOL 文件 293753-05-6.mol
更新日期 2024/07/08 16:38:17
293753-05-6 結構式 293753-05-6 結構式

基本信息

中文別名
化合物SR3335
N-[4-[2,2,2-三氟-1-羥基-1-(三氟甲基)乙基]苯基]-2-噻吩磺酰胺
英文別名
ML-176
SR3335
SR3335
ML176
ML-176
SR-3335
ML-176
SR 3335
SR-3335
ML176
ML 176
SR3335
ML-176
SR 3335
SR-3335
ML176
ML 176
SR 3335 (This product is only available in Japan.)
N-[4-(1,1,1,3,3,3-Hexafluoro-2-hydroxypropan-2-yl)phenyl]thiophene-2-sulfonamide
N-[4-[2,2,2-Trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-2-thiophenesulfonamide
2-Thiophenesulfonamide, N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-
所屬類別
生物化工:激動劑抑制劑

物理化學性質

儲存條件Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
溶解度insoluble in H2O; ≥87.4 mg/mL in EtOH; ≥88.8 mg/mL in DMSO
形態(tài)固體
顏色White to off-white

圖譜信息

常見問題列表

生物活性
SR3335 (ML 176) 是選擇性的 RORα 反向激動劑,可直接結合 RORα,Ki為 220 nM。
靶點

Ki: 220 nM (RORα)

體外研究

SR3335 is a selective RORα partial inverse agonist. In a biochemical radioligand binding assay using [ 3 H]25-hydroxycholesterol as a label it is clear that unlabeled SR3335 dose-dependently competes for binding to the RORα LBD. The K i is calculated as 220 nM using the Cheng-Prusoff equation. In a cell-based chimeric receptor Gal4 DNA-binding domain-NR ligand binding domain cotransfection assay, SR3335 significantly inhibits the constitutive transactivation activity of RORα (IC 50 =480 nM)(partial inverse agonist activity), but has no effect on the activity of LXRα and RORγ.
SR3335 suppresses the expression of endogenous RORα target genes in HepG2 cells that are involved in hepatic gluconeogenesis including glucose-6-phosphatase (G6Pase) and phosphoenolpyruvate carboxykinase (PEPCK).
SR3335 also blocks IL-25 and IL-33-induced ILC2 proliferation and IL-13 production ex vivo.

體內研究

SR3335 displays reasonable exposure following an i.p. injection into mice. The ability of SR3335 is assessed to suppress gluconeogenesis using a diet induced obesity (DIO) mouse model where the mice where treated with 15 mg/kg b.i.d., i.p. for 6-days followed by a pyruvate tolerance test. SR3335 treated mice displays lower plasma glucose levels following the pyruvate challenge consistent with suppression of gluconeogenesis. Importantly, mice treated with SR3335 displayed no difference in body weight or food intake after 7-days of treatment with SR3335.
SR3335 (15 mg/kg/day; ip for 7 days) reduces rhinovirus (RV)-induced lung ILC2s in immature mice (RV infection of 6-day-old BALB/c mice).

"293753-05-6" 相關產品信息